Treatment with difelikefalin (Korsuva) significantly reduced pruritus within 12 weeks, according to a post-hoc analysis of the KALM-1 & KALM-2 phase III trials. Pooling data on maintenance ...

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the European Commission has granted marketing authorization to Kapruvia® ...

A phase 3 trials supports the efficacy and safety of anrikefon for patients with pruritus undergoing maintenance hemodialysis. Anrikefon safely reduces pruritus itch intensity among patients receiving ...

Margaret Yu, MD, is a clinical associate professor of medicine in the division of nephrology at Stanford University School of Medicine and chief of the Stanford Kidney Clinic in Santa Clara, ...

Please provide your email address to receive an email when new articles are posted on . By week 12, itch and pain scores decreased 78.3% and 53.7% in the prurigo nodular and chronic pruritus of ...

STAMFORD, Conn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to ...

The regulator on Tuesday approved odevixibat, an Albireo Pharma drug developed to treat severe itching, or pruritus, in patients who have the liver disorder progressive familial intrahepatic ...

- First and only medication approved in both the U.S. and Europe to treat cholestatic pruritus in patients with Alagille syndrome. - Approval supported by more than six years of LIVMARLI data ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Pruritus and atopic dermatitis-related gene expression were altered after treatment with difelikefalin, ...

ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 (GLOBE NEWSWIRE) -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (CARA) today announced that England’s ...

Between 40% to 70% of polycythemia vera patients report a history of aquagenic pruritus. 33% of these patients avoid contact with water on a daily basis, indicating severe quality-of-life restriction.

To avoid an unnecessary call or office visit, remind patients that itching from a scabies infection may persist for as long as one to two weeks after eradication.There is usually no need for ...